{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T23:23:34Z","timestamp":1791933814196,"version":"4.3.4"},"reference-count":104,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,8,10]],"date-time":"2015-08-10T00:00:00Z","timestamp":1439164800000},"content-version":"vor","delay-in-days":40,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Gilead Sciences Europe Ltd., UK"},{"name":"Dutch Society for Medical Mycology"},{"name":"Department of Medical Microbiology, Radboud University Medical Centre, Nijmegen, The Netherlands"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Resistance Updates"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.drup.2015.08.001","type":"journal-article","created":{"date-parts":[[2015,8,8]],"date-time":"2015-08-08T07:04:18Z","timestamp":1439017458000},"page":"30-40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":303,"special_numbering":"C","title":["International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus"],"prefix":"10.1016","volume":"21-22","author":[{"given":"Paul E.","family":"Verweij","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Ananda-Rajah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Andes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maiken C.","family":"Arendrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger J.","family":"Br\u00fcggemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuradha","family":"Chowdhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver A.","family":"Cornely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Denning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas H.","family":"Groll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Izumikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart Jan","family":"Kullberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrien","family":"Lagrou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Maertens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques F.","family":"Meis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pippa","family":"Newton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iain","family":"Page","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyedmojtaba","family":"Seyedmousavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald C.","family":"Sheppard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Viscoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adilia","family":"Warris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Peter","family":"Donnelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drup.2015.08.001_bib0005","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/myc.12075","article-title":"Itraconazole in chronic cavitary pulmonary aspergillosis: a randomised controlled trial and systematic review of literature","volume":"56","author":"Agarwal","year":"2013","journal-title":"Mycoses"},{"key":"10.1016\/j.drup.2015.08.001_bib0010","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.envres.2014.05.009","article-title":"Occurrence of triazole-resistant Aspergillus fumigatus with TR34\/L98H mutations in outdoor and hospital environment in Kuwait","volume":"133","author":"Ahmad","year":"2014","journal-title":"Environ. Res."},{"key":"10.1016\/j.drup.2015.08.001_bib0015","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1093\/cid\/cit411","article-title":"Long-term antifungal treatment improves health status in patients with chronic pulmonary aspergillosis: a longitudinal analysis","volume":"57","author":"Al-Shair","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.drup.2015.08.001_bib0020","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.drup.2014.01.001","article-title":"Breakpoints for antifungal agents: an update from EUCAST focussing on echinocandins against Candida spp. and triazoles against Aspergillus spp.","volume":"16","author":"Arendrup","year":"2013","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.drup.2015.08.001_bib0025","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1128\/AAC.11.1.21","article-title":"Therapy of murine aspergillosis with amphotericin B in combination with rifampin of 5-fluorocytosine","volume":"11","author":"Arroyo","year":"1977","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2015.08.001_bib0030","doi-asserted-by":"crossref","first-page":"5096","DOI":"10.1128\/AAC.02855-14","article-title":"First detection of TR46\/Y121F\/T289A and TR34\/L98H alterations in Aspergillus fumigatus isolates from azole-naive patients in Denmark despite negative findings in the environment","volume":"58","author":"Astvad","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2015.08.001_bib0035","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/myc.12089","article-title":"Environmental study of azole-resistant Aspergillus fumigatus with TR34\/L98H mutations in the cyp51A gene in Iran","volume":"56","author":"Badali","year":"2013","journal-title":"Mycoses"},{"key":"10.1016\/j.drup.2015.08.001_bib0040","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1086\/652768","article-title":"Factors associated with mortality in transplant patients with invasive aspergillosis","volume":"50","author":"Baddley","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.drup.2015.08.001_bib0045","doi-asserted-by":"crossref","first-page":"4356","DOI":"10.1128\/AAC.00100-15","article-title":"Environmental azole resistant Aspergillus fumigatus in Germany","volume":"59","author":"Bader","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2015.08.001_bib0050","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3201\/eid2007.140087","article-title":"Population-based analysis of invasive fungal infections France, 2001\u20132010","volume":"20","author":"Bitar","year":"2014","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.drup.2015.08.001_bib0055","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1128\/AAC.1.6.476","article-title":"Pharmacological studies with 5-fluorocytosine","volume":"1","author":"Block","year":"1972","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2015.08.001_bib0060","doi-asserted-by":"crossref","first-page":"165rv13","DOI":"10.1126\/scitranslmed.3004404","article-title":"Hidden killers: human fungal infections","volume":"4","author":"Brown","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.drup.2015.08.001_bib0065","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1200\/JCO.1987.5.12.1985","article-title":"Favorable outcome of invasive aspergillosis in patients with acute leukemia","volume":"5","author":"Burch","year":"1987","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.drup.2015.08.001_bib0070","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/AAC.05088-11","article-title":"Rapid induction of multiple resistance mechanisms in Aspergillus fumigatus during azole therapy: a case study and review of the literature","volume":"56","author":"Camps","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2015.08.001_bib0075","first-page":"1","article-title":"Efficacy and safety of nebulised amphotericin B (NAB) in severe asthma with fungal sensitisation (SAFS) and allergic bronchopulmonary aspergillosis (ABPA)","volume":"23","author":"Chishimba","year":"2014","journal-title":"J. Asthma"},{"key":"10.1016\/j.drup.2015.08.001_bib0080","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1128\/JCM.03216-14","article-title":"Validation of a new Aspergillus real-time PCR assay for direct detection of Aspergillus and azole resistance of Aspergillus fumigatus on bronchoalveolar lavage fluid","volume":"53","author":"Chong","year":"2015","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.drup.2015.08.001_bib0085","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/jac\/dkr443","article-title":"Isolation of multiple-triazole-resistant Aspergillus fumigatus strains carrying the TR\/L98H mutations in the cyp51A gene in India","volume":"67","author":"Chowdhary","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.drup.2015.08.001_bib0090","doi-asserted-by":"crossref","first-page":"e1003633","DOI":"10.1371\/journal.ppat.1003633","article-title":"Emergence of azole-resistant Aspergillus fumigatus strains due to agricultural azole use creates an increasing threat to human health","volume":"9","author":"Chowdhary","year":"2013","journal-title":"PLOS Pathog."},{"key":"10.1016\/j.drup.2015.08.001_bib0095","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/jac\/dkt397","article-title":"Azole-resistant Aspergillus fumigatus with the environmental TR46\/Y121F\/T289A mutation in India","volume":"69","author":"Chowdhary","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.drup.2015.08.001_bib0100","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1093\/jac\/dku259","article-title":"Multi-azole-resistant Aspergillus fumigatus in the environment in Tanzania","volume":"69","author":"Chowdhary","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.drup.2015.08.001_bib0105","doi-asserted-by":"crossref","first-page":"428","DOI":"10.3389\/fmicb.2015.00428","article-title":"Prevalence and mechanism of triazole resistance in Aspergillus fumigatus in a referral chest hospital in Delhi, India and an update of the situation in Asia","volume":"6","author":"Chowdhary","year":"2015","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.drup.2015.08.001_bib0110","series-title":"Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi; Approved Standard. Document M38-A2","author":"Clinical Laboratory Standards Institute","year":"2008"},{"key":"10.1016\/j.drup.2015.08.001_bib0115","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1227\/00006123-199504000-00032","article-title":"Invasive central nervous system aspergillosis: cure with liposomal amphotericin B, itraconazole, and radical surgery \u2013 case report and review of the literature","volume":"36","author":"Coleman","year":"1995","journal-title":"Neurosurgery"},{"key":"10.1016\/j.drup.2015.08.001_bib0120","doi-asserted-by":"crossref","first-page":"5798","DOI":"10.1128\/AAC.05134-11","article-title":"Phase II dose escalation study of caspofungin for invasive aspergillosis","volume":"55","author":"Cornely","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2015.08.001_bib0130","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/S0140-6736(03)14472-8","article-title":"Echinocandin antifungal drugs","volume":"362","author":"Denning","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.drup.2015.08.001_bib0150","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1126\/science.aaa6097","article-title":"Infectious disease. How to bolster the antifungal pipeline","volume":"347","author":"Denning","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.drup.2015.08.001_bib0125","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1093\/clinids\/12.6.1147","article-title":"Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases","volume":"12","author":"Denning","year":"1990","journal-title":"Rev. Infect. Dis."},{"key":"10.1016\/j.drup.2015.08.001_bib0135","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1093\/cid\/cir179","article-title":"High-frequency triazole resistance found in nonculturable Aspergillus fumigatus from lungs of patients with chronic fungal disease","volume":"52","author":"Denning","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.drup.2015.08.001_bib0140","first-page":"864","article-title":"Global burden of chronic pulmonary aspergillosis as a sequel to tuberculosis","volume":"89","author":"Denning","year":"2011","journal-title":"Bull. WHO"},{"key":"10.1016\/j.drup.2015.08.001_bib0145","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3109\/13693786.2012.738312","article-title":"Global burden of allergic bronchopulmonary aspergillosis with asthma and its complication chronic pulmonary aspergillosis in adults","volume":"51","author":"Denning","year":"2013","journal-title":"Med. Mycol."},{"key":"10.1016\/j.drup.2015.08.001_bib0155","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1128\/AAC.00301-11","article-title":"In vitro acquisition of secondary azole resistance in Aspergillus fumigatus isolates after prolonged exposure to itraconazole: presence of heteroresistant populations","volume":"56","author":"Escribano","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2015.08.001_bib0160","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1128\/AAC.00636-13","article-title":"Multicenter study of isavuconazole MIC distributions and epidemiological cutoff values for Aspergillus spp. for the CLSI M38-A2 broth microdilution method","volume":"57","author":"Espinel-Ingroff","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2015.08.001_bib0165","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/1749-8090-8-180","article-title":"Results of surgery for chronic pulmonary aspergillosis, optimal antifungal therapy and proposed high risk factors for recurrence \u2013 a National Centre's experience","volume":"8","author":"Farid","year":"2013","journal-title":"J. Cardiothorac. Surg."},{"key":"10.1016\/j.drup.2015.08.001_bib0170","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1128\/CMR.00046-13","article-title":"Tissue penetration of antifungal agents","volume":"27","author":"Felton","year":"2014","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.drup.2015.08.001_bib0175","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/myc.12103","article-title":"Volume dependency for culture of fungi from respiratory secretions and increased sensitivity of Aspergillus quantitative PCR","volume":"57","author":"Fraczek","year":"2014","journal-title":"Mycoses"},{"key":"10.1016\/j.drup.2015.08.001_bib0180","doi-asserted-by":"crossref","first-page":"5778","DOI":"10.1128\/AAC.01141-13","article-title":"In vitro susceptibility of Aspergillus fumigatus to isavuconazole: correlation with itraconazole, voriconazole, and posaconazole","volume":"57","author":"Gregson","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2015.08.001_bib0185","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1086\/315643","article-title":"Comparative efficacy and distribution of lipid formulations of amphotericin B in experimental Candida albicans infection of the central nervous system","volume":"182","author":"Groll","year":"2000","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.drup.2015.08.001_bib0190","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa020191","article-title":"Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis","volume":"347","author":"Herbrecht","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drup.2015.08.001_bib0195","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/bmt.2009.334","article-title":"Caspofungin first-line therapy for invasive aspergillosis in allogeneic hematopoietic stem cell transplant patients: an European Organisation for Research and Treatment of Cancer study","volume":"45","author":"Herbrecht","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.drup.2015.08.001_bib0200","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/cid\/ciu911","volume":"60","author":"Herbrecht","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.drup.2015.08.001_bib0205","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.3201\/eid1507.090043","article-title":"Frequency and evolution of azole resistance in Aspergillus fumigatus associated with treatment failure","volume":"15","author":"Howard","year":"2009","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.drup.2015.08.001_bib0210","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/myc.12047","article-title":"Major variations in Aspergillus fumigatus arising within aspergillomas in chronic pulmonary aspergillosis","volume":"56","author":"Howard","year":"2013","journal-title":"Mycoses"},{"key":"10.1016\/j.drup.2015.08.001_bib0215","doi-asserted-by":"crossref","first-page":"5426","DOI":"10.1128\/AAC.01111-13","article-title":"Determination of isavuconazole susceptibility of Aspergillus and Candida species by the EUCAST method","volume":"57","author":"Howard","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2015.08.001_bib0220","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/13693780701278386","article-title":"Clinical efficacy of micafungin for chronic pulmonary aspergillosis","volume":"45","author":"Izumikawa","year":"2007","journal-title":"Med. Mycol."},{"key":"10.1016\/j.drup.2015.08.001_bib0225","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1128\/AAC.02085-12","article-title":"Favorable outcome of neonatal cerebrospinal fluid shunt-associated Candida meningitis with caspofungin","volume":"57","author":"Jans","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2015.08.001_bib0230","doi-asserted-by":"crossref","first-page":"5180","DOI":"10.1128\/AAC.01111-12","article-title":"Combination of voriconazole and anidulafungin for treatment of triazole-resistant Aspergillus fumigatus in an in vitro model of invasive pulmonary aspergillosis","volume":"56","author":"Jeans","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2015.08.001_bib0235","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1136\/thoraxjnl-2013-203988","article-title":"Cyclical caspofungin for chronic pulmonary aspergillosis in sarcoidosis","volume":"69","author":"Keir","year":"2014","journal-title":"Thorax"},{"key":"10.1016\/j.drup.2015.08.001_bib0240","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1517\/17425255.3.4.573","article-title":"CNS pharmacokinetics of antifungal agents","volume":"3","author":"Kethireddy","year":"2007","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.drup.2015.08.001_bib0245","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/myc.12324","article-title":"Multi-triazole-resistant Aspergillus fumigatus infections in Australia","volume":"58","author":"Kidd","year":"2015","journal-title":"Mycoses"},{"key":"10.1016\/j.drup.2015.08.001_bib0250","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1080\/00365540410020406","article-title":"A multicenter, open-label clinical study of micafungin (FK463) in the treatment of deep-seated mycosis in Japan","volume":"36","author":"Kohno","year":"2004","journal-title":"Scand. J. Infect. Dis."},{"key":"10.1016\/j.drup.2015.08.001_bib0255","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.jinf.2010.08.005","article-title":"Intravenous micafungin versus voriconazole for chronic pulmonary aspergillosis: a multicentre trial in Japan","volume":"61","author":"Kohno","year":"2010","journal-title":"J. Infect."},{"key":"10.1016\/j.drup.2015.08.001_bib0260","first-page":"688","article-title":"Clinical efficacy and safety of micafungin in Japanese patients with chronic pulmonary aspergillosis: a prospective observational study","volume":"49","author":"Kohno","year":"2011","journal-title":"Med. Mycol."},{"key":"10.1016\/j.drup.2015.08.001_bib0265","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s10096-012-1754-z","article-title":"A double-blind comparative study of the safety and efficacy of caspofungin versus micafungin in the treatment of candidiasis and aspergillosis","volume":"32","author":"Kohno","year":"2013","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.drup.2015.08.001_bib0270","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/MD.0b013e318274cd77","article-title":"Central nervous system aspergillosis: a series of 14 cases from a general hospital and review of 123 cases from the literature","volume":"91","author":"Kourkoumpetis","year":"2012","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.drup.2015.08.001_bib0275","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.1128\/AAC.00127-15","article-title":"First description of azole-resistant Aspergillus fumigatus due to TR46\/Y121F\/T289A mutation in France","volume":"59","author":"Lavergne","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2015.08.001_bib0280","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1128\/AAC.38.4.713","article-title":"Pharmacokinetics and safety of a unilamellar liposomal formulation of amphotericin B (AmBisome) in rabbits","volume":"38","author":"Lee","year":"1994","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2015.08.001_bib0285","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1128\/AAC.01279-12","article-title":"Posaconazole pharmacodynamic target determination against wild-type and Cyp51 mutant isolates of Aspergillus fumigatus in an in vivo model of invasive pulmonary aspergillosis","volume":"57","author":"Lepak","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2015.08.001_bib0290","doi-asserted-by":"crossref","first-page":"6284","DOI":"10.1128\/AAC.01355-13","article-title":"Isavuconazole (BAL4815) pharmacodynamic target determination in an in vivo murine model of invasive pulmonary aspergillosis against wild-type and cyp51 mutant isolates of Aspergillus fumigatus","volume":"57","author":"Lepak","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2015.08.001_bib0295","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.1128\/AAC.00185-11","article-title":"Azole resistance in Aspergillus fumigatus isolates from the ARTEMIS global surveillance study is primarily due to the TR\/L98H mutation in the cyp51A gene","volume":"55","author":"Lockhart","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2015.08.001_bib0300","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1111\/j.1469-0691.2011.03548.x","article-title":"Epidemiological trends in invasive aspergillosis in France: the SAIF network (2005\u20132007)","volume":"17","author":"Lortholary","year":"2011","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.drup.2015.08.001_bib0305","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1086\/423381","volume":"39","author":"Maertens","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.drup.2015.08.001_bib0310","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/bmt.2010.175","article-title":"European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL3 2009 update","volume":"46","author":"Maertens","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.drup.2015.08.001_bib0315","doi-asserted-by":"crossref","first-page":"81","DOI":"10.7326\/M13-2508","article-title":"Combination antifungal therapy for invasive aspergillosis: a randomized trial","volume":"162","author":"Marr","year":"2015","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.drup.2015.08.001_bib0320","doi-asserted-by":"crossref","first-page":"727","DOI":"10.2169\/internalmedicine.52.9142","article-title":"Prognostic factors in 194 patients with chronic necrotizing pulmonary aspergillosis","volume":"52","author":"Nakamoto","year":"2013","journal-title":"Intern. Med."},{"key":"10.1016\/j.drup.2015.08.001_bib0325","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1086\/595846","article-title":"Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry","volume":"48","author":"Neofytos","year":"2009","journal-title":"Clin. Infect. Dis."},{"issue":"Suppl. 3","key":"10.1016\/j.drup.2015.08.001_bib0330","first-page":"164","article-title":"The clinical response to a short-term course of intravenous liposomal amphotericin B therapy in patients with chronic pulmonary aspergillosis","volume":"56","author":"Newton","year":"2013","journal-title":"Mycoses"},{"key":"10.1016\/j.drup.2015.08.001_bib0335","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1086\/592255","article-title":"Factors associated with overall and attributable mortality in invasive aspergillosis","volume":"47","author":"Nivoix","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.drup.2015.08.001_bib0340","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.rmed.2012.01.014","article-title":"Clinical characteristics and prognosis of chronic pulmonary aspergillosis","volume":"106","author":"Ohba","year":"2012","journal-title":"Respir. Med."},{"key":"10.1016\/j.drup.2015.08.001_bib0345","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jiac.2015.04.012","article-title":"First determination of azole resistance in Aspergillus fumigatus strains carrying the TR34\/L98H mutations in Turkey","volume":"21","author":"\u00d6zmerdiven","year":"2015","journal-title":"J. Infect. Chemother."},{"key":"10.1016\/j.drup.2015.08.001_bib0350","doi-asserted-by":"crossref","first-page":"644","DOI":"10.3324\/haematol.2009.012054","article-title":"Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study","volume":"95","author":"Pagano","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.drup.2015.08.001_bib0355","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S0140-6736(05)67381-3","article-title":"Advances and challenges in management of invasive mycoses","volume":"366","author":"Patterson","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.drup.2015.08.001_bib0360","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.ijantimicag.2010.08.010","article-title":"The Nationwide Austrian Aspergillus Registry: a prospective data collection on epidemiology, therapy and outcome of invasive mould infections in immunocompromised and\/or immunosuppressed patients","volume":"36","author":"Perkhofer","year":"2010","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.drup.2015.08.001_bib0365","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.1128\/JCM.02387-13","article-title":"Aspergillus PCR-based investigation of fresh tissue and effusion samples in patients with suspected invasive aspergillosis enhances diagnostic capabilities","volume":"51","author":"Reinwald","year":"2013","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.drup.2015.08.001_bib0370","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1111\/j.1469-0691.2008.02086.x","article-title":"EUCAST technical note on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia-forming moulds","volume":"14","author":"Rodriguez-Tudela","year":"2008","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.drup.2015.08.001_bib0375","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S1473-3099(15)70006-X","article-title":"British Society for Medical Mycology best practice recommendations for the diagnosis of serious fungal diseases","volume":"15","author":"Schelenz","year":"2015","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.drup.2015.08.001_bib0420","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1182\/blood-2005-02-0733","article-title":"Improved outcome in central nervous system aspergillosis, using voriconazole treatment","volume":"106","author":"Schwartz","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.drup.2015.08.001_bib0425","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1439-0507.2007.01345.x","article-title":"Poor efficacy of amphotericin B-based therapy in CNS aspergillosis","volume":"50","author":"Schwartz","year":"2007","journal-title":"Mycoses"},{"key":"10.1016\/j.drup.2015.08.001_bib0395","doi-asserted-by":"crossref","first-page":"832","DOI":"10.3201\/eid1905.130075","article-title":"Azole-resistant Aspergillus fumigatus","volume":"19","author":"Seyedmousavi","year":"2013","journal-title":"Iran. Emerg. Infect. Dis."},{"key":"10.1016\/j.drup.2015.08.001_bib0400","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/jac\/dks402","article-title":"Efficacy and pharmacodynamics of voriconazole combined with anidulafungin in azole-resistant invasive aspergillosis","volume":"68","author":"Seyedmousavi","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.drup.2015.08.001_bib0405","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1128\/AAC.02226-12","article-title":"Pharmacodynamics and dose-response relationships of liposomal amphotericin B against different azole-resistant Aspergillus fumigatus isolates in a murine model of disseminated aspergillosis","volume":"57","author":"Seyedmousavi","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2015.08.001_bib0410","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1128\/AAC.04907-14","article-title":"Pharmacodynamics of isavuconazole in an Aspergillus fumigatus mouse infection model","volume":"59","author":"Seyedmousavi","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2015.08.001_bib0380","doi-asserted-by":"crossref","first-page":"e219","DOI":"10.1371\/journal.pmed.0050219","article-title":"Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism","volume":"5","author":"Snelders","year":"2008","journal-title":"PLOS Med."},{"key":"10.1016\/j.drup.2015.08.001_bib0385","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.1128\/AEM.00231-09","article-title":"Possible environmental origin of resistance of Aspergillus fumigatus to medical triazoles","volume":"75","author":"Snelders","year":"2009","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.drup.2015.08.001_bib0390","doi-asserted-by":"crossref","first-page":"e31801","DOI":"10.1371\/journal.pone.0031801","article-title":"Triazole fungicides can induce cross-resistance to medical triazoles in Aspergillus fumigatus","volume":"7","author":"Snelders","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.drup.2015.08.001_bib0415","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1093\/jac\/dku566","article-title":"Emergence of azole-resistant invasive aspergillosis in HSCT recipients in Germany","volume":"70","author":"Steinmann","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.drup.2015.08.001_bib0430","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1086\/510592","article-title":"Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality","volume":"44","author":"Upton","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.drup.2015.08.001_bib0435","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1086\/597465","article-title":"Azole-resistant central nervous system aspergillosis","volume":"48","author":"van der Linden","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.drup.2015.08.001_bib0440","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1128\/JCM.02221-09","article-title":"Rapid diagnosis of azole-resistant aspergillosis by direct PCR using tissue specimens","volume":"48","author":"van der Linden","year":"2010","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.drup.2015.08.001_bib0445","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.3201\/eid1710.110226","article-title":"Clinical implications of azole resistance in Aspergillus fumigatus The Netherlands, 2007\u20132009","volume":"17","author":"van der Linden","year":"2011","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.drup.2015.08.001_bib0450","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/cid\/cit320","article-title":"Aspergillosis due to voriconazole highly resistant Aspergillus fumigatus and recovery of genetically related resistant isolates from domiciles","volume":"57","author":"van der Linden","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.drup.2015.08.001_bib0455","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3201\/eid2106.140717","article-title":"Prospective multicenter international surveillance of azole resistance in Aspergillus fumigatus","volume":"21","author":"van der Linden","year":"2015","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.drup.2015.08.001_bib0460","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/jac\/dku364","article-title":"Azole, polyene and echinocandin MIC distributions for wild-type, TR34\/L98H and TR46\/Y121F\/T289A Aspergillus fumigatus isolates in the Netherlands","volume":"70","author":"van Ingen","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.drup.2015.08.001_bib0465","first-page":"17","article-title":"Azole-resistant Aspergillus fumigatus due to TR46\/Y121F\/T289A mutation emerging in Belgium","author":"Vermeulen","year":"2012","journal-title":"Euro Surveill."},{"key":"10.1016\/j.drup.2015.08.001_bib0470","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/QCO.0000000000000005","article-title":"Azole resistance in Aspergillus fumigatus: a growing public health concern","volume":"26","author":"Vermeulen","year":"2013","journal-title":"Curr. Opin. Infect. Dis."},{"issue":"May","key":"10.1016\/j.drup.2015.08.001_bib0475","article-title":"Epidemiology of azole-resistance in aspergillus disease: a one-year prospective cohort from the Belgian Mycoses Surveillance Network","author":"Vermeulen","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2015.08.001_bib0490","series-title":"Consumption of Antimicrobial Agents and Antimicrobial Resistance among Medically Important Bacteria in the Netherlands","first-page":"94","article-title":"Azole resistance in Aspergillus fumigatus","author":"Verweij","year":"2014"},{"key":"10.1016\/j.drup.2015.08.001_bib0480","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1128\/AAC.00491-08","article-title":"In vitro activities at pH 5.0 and pH 7.0 and in vivo efficacy of flucytosine against Aspergillus fumigatus","volume":"52","author":"Verweij","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2015.08.001_bib0485","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S1473-3099(09)70265-8","article-title":"Azole resistance in Aspergillus fumigatus: a side effect of environmental fungicide use?","volume":"9","author":"Verweij","year":"2009","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.drup.2015.08.001_bib0495","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1093\/jac\/dkp355","article-title":"An EORTC Phase II study of caspofungin as first-line therapy of invasive aspergillosis in haematological patients","volume":"64","author":"Viscoli","year":"2009","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.drup.2015.08.001_bib0500","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1086\/525258","article-title":"Infectious Diseases Society of America Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America","volume":"46","author":"Walsh","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.drup.2015.08.001_bib0505","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1128\/JCM.00667-15","article-title":"Analytical and clinical evaluation of the PathoNostics AsperGenius\u00ae Assay for detection of invasive aspergillosis and resistance to azole antifungal drugs during testing of serum samples","volume":"53","author":"White","year":"2015","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.drup.2015.08.001_bib0515","first-page":"985","article-title":"Short-term efficacy evaluation of chronic pulmonary aspergillosis treated with micafungin and maintenance therapy of itraconazole (article in Japanese)","volume":"47","author":"Yasuda","year":"2009","journal-title":"Nihon Kokyuki Gakkai Zasshi"},{"key":"10.1016\/j.drup.2015.08.001_bib0510","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/00005792-197003000-00002","article-title":"Aspergillosis. The spectrum of the disease in 98 patients","volume":"49","author":"Young","year":"1970","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.drup.2015.08.001_bib0520","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1093\/jac\/dkt071","article-title":"Azole resistance in Aspergillus fumigatus from bronchoalveolar lavage fluid samples of patients with chronic diseases","volume":"68","author":"Zhao","year":"2013","journal-title":"J. Antimicrob. Chemother."}],"container-title":["Drug Resistance Updates"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764615000357?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764615000357?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T07:15:48Z","timestamp":1668755748000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1368764615000357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":104,"alternative-id":["S1368764615000357"],"URL":"https:\/\/doi.org\/10.1016\/j.drup.2015.08.001","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725728133.793528019","asserted-by":"object"}]},"ISSN":["1368-7646"],"issn-type":[{"value":"1368-7646","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus","name":"articletitle","label":"Article Title"},{"value":"Drug Resistance Updates","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drup.2015.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}